Incyte
Data Breaches, Cyber Attacks and Security Report

https://incyte.com  ᛫  Biotech & Pharmaceuticals
Last updated November 16, 2019

About Incyte

Company Overview

Incyte, Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993.Incyte has one drug, Jakafi, which has been approved by the U.S. Food and Drug Administration (FDA) and has been prescribed to several thousands of patients in the United States.As of 2014 the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017.

Valuation

Employees

CEO

Hervé Hoppenot

Location

Data Breaches and Security News

Incyte Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Incyte is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Incyte

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Incyte's security performance with other companies